Burden of Cardio-Cerebrovascular and Renal Diseases Attributable to Systolic Hypertension in France in 2021
Clémence Grave(Santé Publique France), Valérie Olié(l'Assurance Maladie), Jacques Blacher(Université Paris Cité), Laure Carcaillon‐Bentata(Centre de recherche en Epidémiologie et Santé des Populations), A. Gabet(Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail), M Torres(Santé Publique France), Christophe Tzourio(The University of Sydney), Isabelle Durand‐Zaleski(Inserm), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Philippe Gabríel Steg(Mount Sinai Hospital), Christophe Bonaldi(Santé Publique France), Yannick Béjot(Université de Bourgogne)
Cited by 14
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k